Category Archives: Latest

Cardiology innovation and latest information

EECP therapy available in Government Hospital in India

<script async src=”https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7120400376737981″ crossorigin=”anonymous”></script> In India patients will be able to avail treatment using an enhanced external counter pulsation (EECP) equipment at the Mahatma Gandhi Memorial (MGM) government hospital in Trichy from Saturday onwards. EECP is a non invasive treatment for patients with refractory cardiac failure, refractory angina, angina after bypass surgery, patients unwilling or … Continue reading EECP therapy available in Government Hospital in India

Clinical Challenges in the Best Management of Heart Failure and Chronic Obstructive Pulmonary Disease (COPD)

Given the shared risk factors and pathophysiological pathways between heart failure and COPD, it is not surprising that these two conditions frequently coexist. The prognosis of a patient with COPD who is also diagnosed with HF is significantly worse, but vice versa is true for the patient who is already diagnosed with COPD. Even with … Continue reading Clinical Challenges in the Best Management of Heart Failure and Chronic Obstructive Pulmonary Disease (COPD)

In patients with severe acute cardiogenic shock, transcatheter edge-to-edge repair can reduce mitral regurgitation

In patients who arrive with severe acute cardiogenic shock, transcatheter edge-to-edge repair can lessen mitral regurgitation, according to a recent analysis published in the Journal of the American College of Cardiology. Simard et al. conducted a study in conjunction with the American College of Cardiology and the Society of Thoracic Surgeons to better understand how … Continue reading In patients with severe acute cardiogenic shock, transcatheter edge-to-edge repair can reduce mitral regurgitation

J&J spends $16.6 billion to acquire Abiomed, a manufacturer of miniature heart pumps

<script async src=”https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7120400376737981″ crossorigin=”anonymous”></script> Michael Minogue, who is now Abiomed’s chairman, president, and CEO, will retire after the purchase closes. After helping with the transfer, he will hand over leadership of the independent business to Chief Commercial Officer Andrew Greenfield, who will manage J&J’s medtech division. Johnson & Johnson intends to include Abiomed into its … Continue reading J&J spends $16.6 billion to acquire Abiomed, a manufacturer of miniature heart pumps

The most economical and cutting-edge Artificial Heart in development

India is developing the world’s most advanced and affordable Artificial Heart (LVAD), or a Left Ventricular Assist Device. And it is being greeted as the next big thing in world healthcare because an Artificial Heart is rated as one of the most complex machines to build. A left ventricular assist device (LVAD) or Artificial Heart … Continue reading The most economical and cutting-edge Artificial Heart in development

In heart failure patients, being single is linked to a higher chance of death.

<script async src=”https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js?client=ca-pub-7120400376737981″ crossorigin=”anonymous”></script> Unmarried status has been linked to a worse prognosis in both the general population and individuals with coronary artery disease in previous research. The predictive significance of marital status in patients with chronic heart failure was studied in this post-hoc analysis of the Extended Interdisciplinary Network Heart Failure (E-INH) trial. The … Continue reading In heart failure patients, being single is linked to a higher chance of death.

First implanted with Impella Bridge-to-Recovery (BTR)

The first patient in the world has been successfully implanted with Impella Bridge-to-Recovery (BTR) as part of the heart pump’s FDA Early Feasibility Study, according to Abiomed (Nasdaq: ABMD) (EFS). Duc Thinh Pham, MD, and Jane Wilcox, MD, of Northwestern Medicine Bluhm Cardiovascular Institute performed the initial implant. Impella BTR, a forward flow heart pump … Continue reading First implanted with Impella Bridge-to-Recovery (BTR)

After 5 years, there was no difference in all-cause mortality between PCI and CABG in the left main CAD.

On November 15, 2021, The Lancet will publish a paper. Although coronary artery bypass grafting (CABG) has traditionally been the therapy of choice, percutaneous coronary intervention (PCI) with drug-eluting stents is increasingly being used to treat complicated coronary artery disease. According to a recent study presented at the virtual American Heart Association 2021 Scientific Sessions, … Continue reading After 5 years, there was no difference in all-cause mortality between PCI and CABG in the left main CAD.

In older people, aspirin is no longer recommended as a preventative measure against heart attacks and strokes.

There is a scarcity of data on the use of aspirin to help elderly people live longer, healthy lives. It’s unclear whether 5 years of daily low-dose aspirin therapy would extend healthy seniors’ disability-free lives. The study enrolled community-dwelling people in Australia and the United States who were 70 years old or older (or 65 … Continue reading In older people, aspirin is no longer recommended as a preventative measure against heart attacks and strokes.